<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Abortion induced &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/abortion-induced/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Mon, 03 Aug 2026 10:45:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.4</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Abortion induced &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks</title>
		<link>https://clinicaltrials.eu/trial/ropivacaine-hydrochloride-versus-electrolytes-for-pain-relief-in-women-undergoing-second-trimester-medical-abortion-after-13-weeks/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 03 Aug 2026 10:45:59 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/ropivacaine-hydrochloride-versus-electrolytes-for-pain-relief-in-women-undergoing-second-trimester-medical-abortion-after-13-weeks/</guid>

					<description><![CDATA[The study examines pain relief for women undergoing a second trimester medical abortion. The intervention involves a local anesthetic called ropivacaine that is injected around the cervix (a technique known as a paracervical block) to numb the area, while a comparison group receives an injection of a harmless solution called placebo. The purpose of the [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>The study examines pain relief for women undergoing a <b>second trimester medical abortion</b>. The intervention involves a local anesthetic called <b>ropivacaine</b> that is injected around the cervix (a technique known as a paracervical block) to numb the area, while a comparison group receives an injection of a harmless solution called <b>placebo</b>.</p>
<p>The purpose of the study is to reduce the maximum pain experienced during the procedure. Participants receive the injection shortly before the abortion is performed and then follow the standard medical abortion process. Throughout the procedure, pain levels are recorded using a <b>visual analog scale</b>, which is a simple line where a mark indicates how strong the pain feels, allowing researchers to compare the two groups.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Study on Immediate vs. Delayed Insertion of Levonorgestrel IUD for Women After Medical Abortion</title>
		<link>https://clinicaltrials.eu/trial/study-on-immediate-vs-delayed-insertion-of-levonorgestrel-iud-for-women-after-medical-abortion/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 03 Aug 2026 10:08:04 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-immediate-vs-delayed-insertion-of-levonorgestrel-iud-for-women-after-medical-abortion/</guid>

					<description><![CDATA[This clinical trial is focused on studying the use of intrauterine contraception (IUC) following a medical abortion. The study aims to determine if inserting the IUC immediately after the abortion is more effective than waiting 2-4 weeks. The trial involves three types of IUCs: Mirena, Kyleena, and Jaydess, all of which contain the active substance [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying the use of intrauterine contraception (IUC) following a <i>medical abortion</i>. The study aims to determine if inserting the IUC immediately after the abortion is more effective than waiting 2-4 weeks. The trial involves three types of IUCs: <i>Mirena</i>, <i>Kyleena</i>, and <i>Jaydess</i>, all of which contain the active substance <i>levonorgestrel</i>. These devices are small, T-shaped plastic systems placed inside the uterus to prevent pregnancy.</p>
<p>The study will follow participants for up to 12 months to observe how many women continue using the IUC as their method of contraception. Participants will be divided into two groups: one receiving the IUC immediately after the abortion and the other receiving it after a delay. Researchers will check in with participants at 3, 6, and 12 months to gather information on the use of IUC, any difficulties with insertion, pain levels, and any complications such as bleeding or infections. They will also record any pregnancies that occur during the study period.</p>
<p>The purpose of this study is to find out which timing for IUC insertion is more acceptable and effective for women after a medical abortion. The study will also look at how easy the insertion process is for healthcare providers and how women feel about the procedure. This information will help improve post-abortion care and provide better contraceptive options for women.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
